Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet;RM mammaria a contrasto dinamico a basso campo e magnete aperto in pazienti claustrofobiche o obese

Radiologia Medica

Volumn 114, Issue 2, 2009, Pages 267-285

  Calabrese, M ^a   Brizzi, D ^a   Carbonaro, L ^b   Chiaramondia, M ^a   Kirchin, M A ^c   Sardanelli, F ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Bracco Imaging Spa ^*  (Italy)

Author keywords

Breast cancer; Gadobenate dimeglumine (Gd BOPTA); Low field open magnets; Magnetic resonance imaging

Indexed keywords

GADOBENATE DIMEGLUMINE;

ACCURACY; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BODY SIZE; BREAST; BREAST CYST; BREAST LESION; CANCER INVASION; CLAUSTROPHOBIA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; MAGNETIC FIELD; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; EQUIPMENT DESIGN; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OVERWEIGHT; PHOBIC DISORDERS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 64949155642     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-008-0358-2     Document Type: Article

References (61)

1. C. Kuhl 2007 The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice Radiology 244 356 378
2. Sardanelli F, Giuseppetti GM, Canavese G et al (2008) Indications for breast magnetic resonance imaging. Consensus document "Attualità in Senologia", Florence 2007. Radiol Med (2008) Oct 16 [Epub ahead of print] DOI:10.1007/s11547-008-0340-z
3. F. Sardanelli A. Iozzelli A. Fausto 2003 MR imaging of the breast: indications, established technique, and new directions Eur Radiol 13 3 N28 N36
4. F. Baum U. Fischer R. Vosshenrich E. Grabbe 2002 Classification of hypervascularized lesions in CE MR imaging of the breast Eur Radiol 12 1087 1092
5. L. Ballesio C. Maggi S. Savelli 2008 Role of breast magnetic resonance imaging (MRI) in patients with unilateral nipple discharge: preliminary study Radiol Med 113 249 264
6. A. Fausto A. Magaldi B. Babaei Paskeh 2007 MR imaging and proton spectroscopy of the breast: how to select the images useful to convey the diagnostic message Radiol Med 112 1060 1068
7. A. Cilotti C. Iacconi C. Marini 2007 Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications Radiol Med 112 272 286
8. F. Sardanelli G.M. Giuseppetti P. Panizza 2004 Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard AJR Am J Roentgenol 183 1149 1157
9. F. Sardanelli F. Podo G. D'Agnolo 2007 Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results Radiology 242 698 715
10. S.C. Michel A. Rake L. Götzmann 2002 Pelvimetry and patient acceptability compared between open 0.5-T and closed 1.5-T MR systems Eur Radiol 12 2898 2905
11. P.A. Rothschild J.M. Domesek M.E. Eastham L. Kaufman 1991 MR imaging of excessively obese patients: the use of an open permanent magnet Magn Reson Imaging 9 151 154
12. P. Steiner A.W. Schoenenberger E.A. Penner 1996 Interactive stereotactic interventions in superconducting, open 0.5-Tesla MRI tomography Rofo 165 276 280
13. H. Sittek C. Perlet K. Herrmann 1997 MR mammography. Preoperative marking of non-palpable breast lesions with the Magnetom open at 0.2 T Radiologe 37 685 691
14. H. Sittek E. Linsmeier C. Perlet 2000 Preoperative marking and biopsy of nonpalpable breast lesions with a guidance system for the open Magnetom Radiologe 40 1098 1105
15. E. Pääkkö H. Reinikainen E.L. Lindholm T. Rissanen 2005 Low-field versus high-field MRI in diagnosing breast disorders Eur Radiol 15 1361 1368
16. F. Sardanelli A. Iozzelli A. Fausto 2002 Contrast agents and temporal resolution in breast MR imaging J Exp Clin Cancer Res 21 3 69 75
17. M. Rohrer H. Bauer J. Mintorovitch 2005 Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths Invest Radiol 40 715 724
18. J. Pintaske P. Martirosian H. Graf 2006 Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla Invest Radiol 41 213 221
19. M.V. Knopp M.W. Bourne F. Sardanelli 2003 Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine AJR Am J Roentgenol 181 663 676
20. F. Sardanelli A. Iozzelli A. Fausto 2005 Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity Radiology 235 791 797
21. F. Pediconi C. Catalano A. Roselli 2007 Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions Radiology 243 670 680
22. F. Pediconi C. Catalano S. Padula 2007 Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer? Breast Cancer Res Treat 106 65 74
23. F. Pediconi C. Catalano R. Occhiato 2005 Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine Radiology 237 45 56
24. American College of Radiology (ACR) (1998) Breast imaging reporting and data system (BI-RADS). 3rd edn. American College of Radiology, Reston
25. F. Sardanelli A. Fausto A. Iozzelli 2004 Dynamic breast magnetic resonance imaging: effect of changing the region of interest on early enhancement using 2D and 3D techniques J Comput Assist Tomogr 28 642 646
26. U. Fischer L. Kopka E. Grabbe 1999 Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach Radiology 213 881 888
27. F. Sardanelli A. Fausto A. Esseridou 2008 Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance Invest Radiol 43 236 242
28. Association of Directors of Anatomic and Surgical Pathology (ADASP) (2004) Breast carcinoma guideline. Recommendations for the reporting of breast carcinoma. Version 1.1 www.adasp.org/Checklists/checklists/BREAST%20- %20GUIDELINE%20-%20v1.1.pdf (accesed 10/2008)
29. Tavassoli FA, Devilee P (2003) World Health Organization tumours of the breast and female genital organs. In: Kleihues P, Sobin L (eds) World Health Organization classification of tumours. IARC Press, Lyon, pp 35-36
30. J.M. Bland D.G. Altman 1999 Measuring agreement in method comparison studies Stat Methods Med Res 8 135 160
31. J.P. Weir 2005 Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM J Strength Cond Res 19 231 240
32. M. Komu M. Kormano 1992 Breast coil design for low-field MRI Magn Reson Med 27 165 170
33. S. Frankel K. Occhipinti L. Kaufman 1994 Characteristics of magnetic resonance sequences used for imaging silicone gel, saline, and gel-saline implants at low field strengths Invest Radiol 29 781 786
34. K.I. Dean M. Komu 1994 Breast tumor imaging with ultra low field MRI Magn Reson Imaging 12 395 401
35. J. Thiele J.P. Schneider P. Franke 1998 New method of MR-guided mammary biopsy Rofo 168 374 379
36. A.R. Carmichael 2006 Obesity as a risk factor for development and poor prognosis of breast cancer BJOG 113 1160 1166
37. National Center for Health Statistics, Health, United States (2006) http://www.cdc.gov/nchs/fastats/overwt.htm (accessed 10/2008)
38. C.L. Ogden M.D. Carroll L.R. Curtin 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 1549 1555
39. D. Saslow C. Boetes W. Burke 2007 American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 75 89
40. F. Thibault C. Nos M. Meunier 2004 Institut Curie Breast Cancer Group MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy AJR Am J Roentgenol 183 1159 1168
41. U. Fischer F. Baum S. Luftner-Nagel 2006 Preoperative MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis Magn Reson Imaging Clin N Am 14 351 362
42. V. Londero M. Bazzocchi C. Del Frate 2004 Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy Eur Radiol 14 1371 1379
43. A.R. Padhani C. Hayes L. Assersohn 2006 Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results Radiology 239 361 374
44. H. Kawashima O. Matsui M. Suzuki 2000 Breast cancer in dense breast: detection with contrast-enhanced dynamic MR imaging J Magn Reson Imaging 11 233 243
45. S.H. Heywang-Köbrunner U. Bick W.G. Bradley Jr 2001 International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions Eur Radiol 11 531 546
46. R.M. Warren L. Pointon D. Thompson 2005 Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis Radiology 236 779 788
47. M.D. Schnall J. Blume D.A. Bluemke 2006 Diagnostic architectural and dynamic features at breast MR imaging: multicenter study Radiology 238 42 53
48. N. Tuncbilek H.M. Karakas O.O. Okten 2005 Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors Eur J Radiol 53 500 505
49. S. Wurdinger A.B. Herzog D.R. Fischer 2005 Differentiation of phyllodes breast tumors from fibroadenomas on MRI AJR Am J Roentgenol 185 1317 1321
50. C. de Haën M. Cabrini L. Akhnana 1999 Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium J Comput Assist Tomogr 23 1 S161 S168
51. F.M. Cavagna F. Maggioni P.M. Castelli 1997 Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 780 796
52. L.E. Philpotts 2005 Will improved vascular mapping achieved with gadobenate dimeglumine aid in interpretation of breast MR images? Radiology 235 717 718
53. L. Marti-Bonmati M. Kormano 1997 MR equipment acquisition strategies: low-field or high-field scanners Eur Radiol 7 5 S263 S268
54. D.R. Broome M.S. Girguis P.W. Baron 2007 Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned AJR Am J Roentgenol 188 586 592
55. E.A. Sadowski L.K. Bennett M.R. Chan 2007 Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 148 157
56. B.L. Daniel R.L. Birdwell D.M. Ikeda 1998 Breast lesion localization: a freehand, interactive MR imaging-guided technique Radiology 207 455 463
57. J.P. Schneider T. Schulz L.C. Horn 2002 MR-guided percutaneous core biopsy of small breast lesions: first experience with a vertically open 0.5T scanner J Magn Reson Imaging 15 374 385
58. M.A. van den Bosch B.L. Daniel S. Pal 2006 MRI-guided needle localization of suspicious breast lesions: results of a freehand technique Eur Radiol 16 1811 1817
59. R.B. Sequeiros H. Reinikainen A.M. Sequeiros 2007 MR-guided breast biopsy and hook wire marking using a low-field (0.23 T) scanner with optical instrument tracking Eur Radiol 17 813 819
60. D. Hailey 2006 Open magnetic resonance imaging (MRI) scanners Issues Emerg Health Technol 92 1 4
61. P.L. Pereira B. Kastler J. Wiskirchen 2007 Interventional MR imaging in musculoskeletal J Radiol 88 1230 1237